Cargando…
Potential Molecular Mechanism of Upregulated Aryl Hydrocarbon Receptor Nuclear Translocator 2 in Nasopharyngeal Carcinoma
BACKGROUND: Currently, the benefits of nasopharyngeal carcinoma (NPC) therapy are limited, and it is necessary to further explore possible therapeutic targets. Aryl hydrocarbon receptor nuclear translocator 2 (ARNT2) has been extensively studied in other cancer species, but little has been explored...
Autores principales: | Huang, Si-Wei, Chen, Gang, Li, Jian-Di, Qin, Li-Ting, Huang, Zhi-Guang, Huang, Su-Ning, Lu, Wei, Zeng, Jiang-Hui, Mo, Bin-Yu, Dang, Yi-Wu, Wei, Zhu-Xin, Luo, Jia-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532129/ https://www.ncbi.nlm.nih.gov/pubmed/36203533 http://dx.doi.org/10.1155/2022/9137282 |
Ejemplares similares
-
Upregulation of aryl hydrocarbon receptor nuclear translocator 2 in the hippocampi of post-stroke depression rats
por: Pei, Chen-Di, et al.
Publicado: (2019) -
Hepatic Aryl hydrocarbon Receptor Nuclear Translocator (ARNT) regulates metabolism in mice
por: Scott, Christopher H., et al.
Publicado: (2017) -
Aryl Hydrocarbon Receptor Nuclear Translocator in Vascular Smooth Muscle Cells Is Required for Optimal Peripheral Perfusion Recovery
por: Borton, Anna Henry, et al.
Publicado: (2018) -
Myeloid cell deletion of Aryl hydrocarbon Receptor Nuclear Translocator (ARNT) induces non-alcoholic steatohepatitis
por: Scott, Christopher, et al.
Publicado: (2019) -
Aryl Sulfonamides Induce Degradation of Aryl Hydrocarbon Receptor Nuclear Translocator through CRL4(DCAF15) E3 Ligase
por: Kim, Sung Ah, et al.
Publicado: (2020)